CATALYST PHARMACEUTICALS, INC. (CPRX) › Cost of RevenueCATALYST PHARMACEUTICALS, INC. (CPRX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2019: $14.76M2020: $17.04M2021: $21.88M2022: $34.39M2023: $51.97M2024: $68.84M2025: $87.25M$87.25M2019Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$87.25M+26.7%2024$68.84M+32.5%2023$51.97M+51.1%2022$34.39M+57.2%2021$21.88M+28.4%2020$17.04M+15.4%2019$14.76M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share